Patents by Inventor Iain Andrew Sharpe

Iain Andrew Sharpe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONOTOXIN PEPTIDES USEFUL AS INHIBITORS OF NEURONAL AMINE TRANSPORTERS
    Publication number: 20120277166
    Abstract: The invention relates to an isolated, synthetic or recombinant ?-conotoxin peptide having the ability to inhibit a neuronal amine transporter, nucleic acid molecules encoding all or part of such peptides, antibodies to such peptides and uses and methods of treatment involving them.
    Type: Application
    Filed: May 25, 2011
    Publication date: November 1, 2012
    Applicant: XENOME LIMITED
    Inventors: Richard James Lewis, Paul Francis Alewood, Iain Andrew Sharpe
  • NOVEL PEPTIDES
    Publication number: 20090275498
    Abstract: The invention relates to an isolated, synthetic or recombinant ?-conotoxin peptide having the ability to inhibit a neuronal amine transporter, nucleic acid molecules encoding all or part of such peptides, antibodies to such peptides and uses and methods of treatment involving them.
    Type: Application
    Filed: November 2, 2007
    Publication date: November 5, 2009
    Applicant: The University of Queensland
    Inventors: Richard James Lewis, Paul Francis Alewood, Iain Andrew Sharpe
  • Conotoxin peptides
    Patent number: 7326682
    Abstract: The invention relates to an isolated, synthetic or recombinant ?-conotoxin peptide having the ability to inhibit a neuronal amine transporter, nucleic acid molecules encoding all or part of such peptides, antibodies to such peptides and uses and methods of treatment involving them.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: February 5, 2008
    Assignee: Xenome Limited
    Inventors: Richard James Lewis, Paul Francis Alewood, Iain Andrew Sharpe
  • Peptides
    Patent number: 6849601
    Abstract: The present invention relates to novel peptides and derivatives thereof useful as selective ?1-adrenoceptor antagonists which ability of inhibiting the agonist action of agonist noradrenaline on the ?1-adrenoceptor is greater than their ability of inhibiting the action of agonist noradrenaline on the other ?-adrenoceptors. The invention also relates to pharmaceutical compositions comprising these peptides.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: February 1, 2005
    Assignee: The University of Queensland
    Inventors: Richard James Lewis, Paul Francis Alewood, Iain Andrew Sharpe
  • Peptides
    Patent number: 6794361
    Abstract: The invention relates to an isolated, synthetic or recombinant &khgr;-conotoxin peptide having the ability to inhibit a neuronal amine transporter, nucleic acid molecules encoding all or part of such peptides, antibodies to such peptides and uses and methods of treatment involving them.
    Type: Grant
    Filed: June 27, 2001
    Date of Patent: September 21, 2004
    Assignee: The University of Queensland
    Inventors: Richard James Lewis, Paul Francis Alewood, Iain Andrew Sharpe